Literature DB >> 22187097

Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty: analysis from the RECORD trials.

Danny M Cohn1, Jeroen Hermanides, J Hans DeVries, Pieter-Willem Kamphuisen, Silvia Kuhls, Martin Homering, Joost B L Hoekstra, Anthonie W A Lensing, Harry R Büller.   

Abstract

Stress-induced hyperglycaemia is common during orthopaedic surgery. In addition, hyperglycaemia activates coagulation. The aim of the study was to assess whether stress-induced hyperglycaemia is associated with symptomatic or asymptomatic venous thromboembolism (VTE) following orthopaedic surgery. We performed post-hoc analyses in the four RECORD studies (REgulation of Coagulation in major Orthopaedic surgery reducing the Risk of Deep venous thrombosis and pulmonary embolism). Separate analyses were performed for patients undergoing elective total hip or knee replacement. Outcome measures were symptomatic VTE and "total VTE" (defined as the composite of symptomatic VTE, asymptomatic DVT assessed by per protocol venography and all cause mortality). Glucose levels were measured pre-op and 6 hours post-op, categorised into quartiles, based on the distribution in the respective cohorts. The influence of glucose, adjusted for body mass index, age, gender and diabetes mellitus on VTE was assessed by logistic regression analyses. A total of 12,383 patients were eligible for assessment of symptomatic VTE, and 8,512 patients were eligible for assessment of total VTE. Increased glucose levels after total hip replacement were associated with total VTE; adjusted odds ratio (OR) highest versus lowest quartile 1.9 (95% confidence interval [CI] 1.3 to 3.0). Furthermore, increase in glucose levels during total hip replacement was associated with total VTE (OR highest versus lowest quartile 1.8 (95%CI 1.2 to 2.8). This was not observed in patients undergoing total knee replacement, probably due to differences in the applied surgical procedures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22187097     DOI: 10.1160/TH11-07-0447

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Blood glucose as a marker of venous thromboembolism in critically ill children.

Authors:  J A Tala; C T Silva; S Pemira; E Vidal; E V S Faustino
Journal:  J Thromb Haemost       Date:  2014-06       Impact factor: 5.824

2.  Risk factors for perioperative hyperglycemia in primary hip and knee replacements.

Authors:  Esa Jämsen; Pasi I Nevalainen; Antti Eskelinen; Jarkko Kalliovalkama; Teemu Moilanen
Journal:  Acta Orthop       Date:  2014-11-18       Impact factor: 3.717

3.  Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case-control study.

Authors:  Ruifang Li-Gao; Vânia M Morelli; Willem M Lijfering; Suzanne C Cannegieter; Frits R Rosendaal; Astrid van Hylckama Vlieg
Journal:  Br J Haematol       Date:  2018-11-27       Impact factor: 6.998

4.  High level of neutrophil to lymphocyte ratio increases the risk of deep venous thrombosis in intensive care unit patients after oral cancer surgery: a retrospective study.

Authors:  Lu Peng; Qiang Bao; Xiaoli Hong; Weichao Li; Yukai Zheng; Zijun Zou; Wenhua Liao; Canxia Huang
Journal:  Ann Transl Med       Date:  2022-07

5.  Association between hyperglycemia on admission and preoperative deep venous thrombosis in patients with femoral neck fractures.

Authors:  Qiaomei Lv; Wenbo Ding; Wei Yao; Wanyun Tang; Wei Wang
Journal:  BMC Musculoskelet Disord       Date:  2022-10-06       Impact factor: 2.562

6.  Lowering blood glucose during hip surgery does not influence coagulation activation.

Authors:  Marjolein K Sechterberger; Jeroen Hermanides; Rudolf W Poolman; Jasper E Kal; Joost C M Meijers; Joost B L Hoekstra; J Hans DeVries
Journal:  BBA Clin       Date:  2015-03-11

Review 7.  Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis.

Authors:  Yuhong Mi; Shufeng Yan; Yanhui Lu; Ying Liang; Chunsheng Li
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.